ESC 365 - Real world experience of introducing the new heart failure drug LCZ 696 in ambulatory care setting

HFA Premium Access

Real world experience of introducing the new heart failure drug LCZ 696 in ambulatory care setting

Session: Poster session 3 - Renin-angiotensin-aldosterone antagonists

Topic: Renin-angiotensin-aldosterone antagonists

Speaker: Ms L. O'connor (Dublin, IE)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Congress Presentation

About the speaker

Ms Laura O'connor

Beaumont Hospital, Dublin (Ireland)

0 follower

2 more presentations in this session

Effect of renin-angiotensin antagonist in patients with impaired renal function and heart failure: results from KorAHF registry

Speaker: Assistant Professor S. Jang (Daegu, KR)

Influence of long-lasting treatment with ramipril and eprosartan on diastolic dysfunction and insulin resistance

Speaker: Doctor N. Sapojnic (Chisinau, MD)

Access the full session

Poster session 3 - Renin-angiotensin-aldosterone antagonists

Speakers: Ms L. O'connor, Assistant Professor S. Jang, Doctor N. Sapojnic

About the event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April - 2 May 2017

Sessions Presentations

Congress

ESC 365 is supported by